The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.20 - Manufacture of pharmaceutical preparations
1,000 jobs Number of planned job losses
Announcement Date
19 January 2022
Employment effect (start)
19 January 2022
Foreseen end date
31 January 2024
Description
Leo Pharma, a Danish company in medical dermatology, has announced a new operating model and it will cut 1,000 positions worldwide over the next two years. The plan aims at optimising the commercial part of the business and the R&D organisation as well as to increase its international competitiveness. Sixty-eight employees have already been dismissed. The company does not want to reveal where all the dismissals will take place, but has promised to support its ex-employees.
LEO Pharma was founded in 1908 and is headquartered in Ballerup, Denmark. Globally, it employs 6,000 people. In 2020, the company had a turnover of DKK 10 billion.
Eurofound (2022), Leo Pharma, Internal restructuring in World, factsheet number 106266, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/106266.